• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

包括华氏巨球蛋白血症在内的副蛋白分泌性疾病中的高黏滞综合征

Hyperviscosity Syndrome in Paraprotein Secreting Conditions Including Waldenstrom Macroglobulinemia.

作者信息

Weaver Allison, Rubinstein Samuel, Cornell Robert F

机构信息

Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.

出版信息

Front Oncol. 2020 May 19;10:815. doi: 10.3389/fonc.2020.00815. eCollection 2020.

DOI:10.3389/fonc.2020.00815
PMID:32509586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7248405/
Abstract

Hyperviscosity syndrome is a serious complication associated with high levels of paraproteins in patients with hematological malignancies. Therapeutic advances in disease control may reduce the incidence of hyperviscosity syndrome; however, management of acute cases requires an understanding of key symptoms and prompt treatment to mitigate serious consequences.

摘要

高黏滞血症是血液系统恶性肿瘤患者中与高水平副蛋白相关的一种严重并发症。疾病控制方面的治疗进展可能会降低高黏滞血症的发生率；然而，急性病例的处理需要了解关键症状并及时治疗以减轻严重后果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cd4/7248405/06eacc64314e/fonc-10-00815-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cd4/7248405/06eacc64314e/fonc-10-00815-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cd4/7248405/06eacc64314e/fonc-10-00815-g0001.jpg

相似文献

1
Hyperviscosity Syndrome in Paraprotein Secreting Conditions Including Waldenstrom Macroglobulinemia.包括华氏巨球蛋白血症在内的副蛋白分泌性疾病中的高黏滞综合征
Front Oncol. 2020 May 19;10:815. doi: 10.3389/fonc.2020.00815. eCollection 2020.
2
Hyperviscosity in plasma cell dyscrasias.浆细胞异常增生症中的高黏滞血症
Clin Hemorheol Microcirc. 2013;55(1):75-83. doi: 10.3233/CH-131691.
3
Management of intraoral bleeding in patients with Waldenström macroglobulinemia: A protocol proposal.华氏巨球蛋白血症患者口腔内出血的管理：一项方案建议。
Spec Care Dentist. 2020 Jan;40(1):134-141. doi: 10.1111/scd.12440. Epub 2019 Dec 2.
4
A case of hyperviscosity syndrome associated with Waldenström macroglobulinemia treated with membrane plasma exchange without predilution.1例伴华氏巨球蛋白血症的高黏滞综合征患者接受无预稀释的膜式血浆置换治疗。
CEN Case Rep. 2025 Feb;14(1):90-94. doi: 10.1007/s13730-024-00912-z. Epub 2024 Jul 4.
5
[Hyperviscosity syndrome].[高黏滞综合征]
Rev Med Interne. 2015 Sep;36(9):588-95. doi: 10.1016/j.revmed.2015.02.005. Epub 2015 Mar 13.
6
Hyperviscosity syndrome secondary to a myeloma-associated IgG(1)kappa paraprotein strongly reactive against the HIV-1 p24 gag antigen.继发于骨髓瘤相关IgG(1)κ副蛋白的高黏滞综合征，该副蛋白对HIV-1 p24 gag抗原具有强烈反应性。
Am J Hematol. 2000 Jul;64(3):210-3. doi: 10.1002/1096-8652(200007)64:3<210::aid-ajh13>3.0.co;2-#.
7
Advances in the treatment of Waldenström's macroglobulinemia.华氏巨球蛋白血症的治疗进展
Expert Rev Anticancer Ther. 2006 Mar;6(3):329-34. doi: 10.1586/14737140.6.3.329.
8
Therapeutic apheresis in hyperleukocytosis and hyperviscosity syndrome.高白细胞血症和高黏滞综合征中的治疗性血液成分单采术
Semin Thromb Hemost. 2007 Jun;33(4):350-4. doi: 10.1055/s-2007-976170.
9
Hyperviscosity syndrome in plasma cell dyscrasias.浆细胞异常增生症中的高黏滞综合征
Semin Thromb Hemost. 2003 Oct;29(5):467-71. doi: 10.1055/s-2003-44554.
10
Hyperviscosity syndrome in paraproteinemia. Managed by plasma exchange; monitored by serum tests.副蛋白血症中的高黏滞综合征。通过血浆置换进行治疗；通过血清检测进行监测。
Transfusion. 1982 Jan-Feb;22(1):51-3. doi: 10.1046/j.1537-2995.1982.22182154217.x.

引用本文的文献

1
Exchange transfusion and pre-filter apheresis dilution for hyperviscosity syndrome refractory to conventional therapeutic plasma exchange in a patient with IgA multiple myeloma.对于一名患有IgA多发性骨髓瘤且常规治疗性血浆置换难治的高黏滞血症患者，采用换血疗法及预滤单采稀释法进行治疗。
Transfusion. 2025 Apr;65(4):779-784. doi: 10.1111/trf.18188. Epub 2025 Mar 24.
2
Viscous Vengeance: A Case Report of Hyperviscosity Syndrome in IgA Lambda Multiple Myeloma.黏性复仇：一例 IgA λ 型多发性骨髓瘤高黏滞血症综合征的病例报告
J Community Hosp Intern Med Perspect. 2024 Sep 9;14(5):92-95. doi: 10.55729/2000-9666.1397. eCollection 2024.
3

本文引用的文献

1
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue.临床实践中治疗性血液成分单采术的使用指南——美国血液成分单采学会写作委员会基于证据的方法：第八期特刊
J Clin Apher. 2019 Jun;34(3):171-354. doi: 10.1002/jca.21705.
2
Rituximab-based combination therapy in patients with Waldenström macroglobulinemia: a systematic review and meta-analysis.基于利妥昔单抗的联合疗法治疗华氏巨球蛋白血症患者：一项系统评价和荟萃分析。
Onco Targets Ther. 2019 Apr 11;12:2751-2766. doi: 10.2147/OTT.S191179. eCollection 2019.
3
A case of hyperviscosity syndrome associated with Waldenström macroglobulinemia treated with membrane plasma exchange without predilution.
1例伴华氏巨球蛋白血症的高黏滞综合征患者接受无预稀释的膜式血浆置换治疗。
CEN Case Rep. 2025 Feb;14(1):90-94. doi: 10.1007/s13730-024-00912-z. Epub 2024 Jul 4.
4
Management of hematological patients requiring emergency chemotherapy in the intensive care unit.重症监护病房中需要紧急化疗的血液学患者的管理。
Intensive Care Med. 2024 Jun;50(6):849-860. doi: 10.1007/s00134-024-07454-z. Epub 2024 May 15.
5
The Application of Fluorescence Anisotropy for Viscosity Measurements of Small Volume Biological Analytes.荧光各向异性在小体积生物分析物粘度测量中的应用。
J Exp Theor Anal. 2023 Dec;1(2):86-96. doi: 10.3390/jeta1020007. Epub 2023 Dec 1.
6
A Case of IgG1-Lambda Multiple Myeloma With Hyperviscosity Syndrome and Cryoglobulinemia: Identification of the Subclass Fraction by Immunoelectrophoresis and Immunofixation Electrophoresis.1例伴有高黏滞综合征和冷球蛋白血症的IgG1-λ型多发性骨髓瘤：通过免疫电泳和免疫固定电泳鉴定亚类组分
Cureus. 2023 Nov 4;15(11):e48253. doi: 10.7759/cureus.48253. eCollection 2023 Nov.
7
Advances in Management of the Stroke Etiology One-Percenters.卒中病因百分之一患者管理的新进展。
Curr Neurol Neurosci Rep. 2023 Jun;23(6):301-325. doi: 10.1007/s11910-023-01269-z. Epub 2023 May 29.
8
Pulmonary hypertension in patients with multiple myeloma: A comprehensive review.多发性骨髓瘤患者的肺动脉高压：全面综述
Pulm Circ. 2023 Apr 1;13(2):e12210. doi: 10.1002/pul2.12210. eCollection 2023 Apr.
9
Differential Diagnosis of Waldenström's Macroglobulinemia and Early Management: Perspectives from Clinical Practice.华氏巨球蛋白血症的鉴别诊断与早期管理：临床实践视角
Blood Lymphat Cancer. 2022 Aug 18;12:107-117. doi: 10.2147/BLCTT.S259860. eCollection 2022.
10
Hyperviscosity syndromes; hemorheology for physicians and the use of microfluidic devices.高黏滞血症；血液流变学与医师实用及微流控器械的应用。
Curr Opin Hematol. 2022 Nov 1;29(6):290-296. doi: 10.1097/MOH.0000000000000735. Epub 2022 Jul 18.
Waldenström's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
华氏巨球蛋白血症：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2019 May 1;30(5):860-862. doi: 10.1093/annonc/mdy466.
4
Hyperviscosity syndrome in splenic marginal zone lymphoma.脾边缘区淋巴瘤中的高黏滞综合征
Blood. 2018 Oct 11;132(15):1627. doi: 10.1182/blood-2018-07-863787.
5
Ibrutinib Monotherapy in Symptomatic, Treatment-Naïve Patients With Waldenström Macroglobulinemia.伊布替尼单药治疗有症状、初治的华氏巨球蛋白血症患者。
J Clin Oncol. 2018 Sep 20;36(27):2755-2761. doi: 10.1200/JCO.2018.78.6426. Epub 2018 Jul 25.
6
Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström's Macroglobulinemia.伊布替尼联合利妥昔单抗治疗华氏巨球蛋白血症的 3 期临床试验。
N Engl J Med. 2018 Jun 21;378(25):2399-2410. doi: 10.1056/NEJMoa1802917. Epub 2018 Jun 1.
7
Serum IgM level as predictor of symptomatic hyperviscosity in patients with Waldenström macroglobulinaemia.血清IgM水平作为华氏巨球蛋白血症患者症状性高黏滞血症的预测指标
Br J Haematol. 2017 Jun;177(5):717-725. doi: 10.1111/bjh.14743. Epub 2017 May 9.
8
Emergencies in Hematology and Oncology.血液学与肿瘤学中的急症
Mayo Clin Proc. 2017 Apr;92(4):609-641. doi: 10.1016/j.mayocp.2017.02.008.
9
Plasma exchange in the intensive care unit: Technical aspects and complications.重症监护病房中的血浆置换：技术要点与并发症
J Clin Apher. 2017 Dec;32(6):405-412. doi: 10.1002/jca.21529. Epub 2017 Feb 1.
10
Allogeneic Transplantation for Relapsed Waldenström Macroglobulinemia and Lymphoplasmacytic Lymphoma.异基因移植治疗复发的华氏巨球蛋白血症和淋巴浆细胞淋巴瘤。
Biol Blood Marrow Transplant. 2017 Jan;23(1):60-66. doi: 10.1016/j.bbmt.2016.10.010. Epub 2016 Oct 24.